Interlaboratory proficiency processing scheme in CSF aliquoting implementation and assessment based on biomarkers of Alzheimer's disease von Lewczuk, Piotr, Gaignaux, Amélie, Kofanova, Olga, Ermann, Natalia, Betsou, Fay, Brandner, Sebastian, Mroczko, Barbara, Blennow, Kaj, Strapagiel, Dominik, Paciotti, Silvia, Vogelgsang, Jonathan, Roehrl, Michael H., Mendoza, Sandra, Kornhuber, Johannes, Teunissen, Charlotte

Volltext öffnen

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease von Ramirez, Alfredo, Flier, Wiesje M. van der, Herold, Christine, Ramonet, David, Heilmann, Stefanie, Lewczuk, Piotr, Popp, Julius, Lacour, André, Drichel, Dmitriy, Louwersheimer, Eva, Kummer, Markus P., Cruchaga, Carlos, Hoffmann, Per, Teunissen, Charlotte, Holstege, Henne, Kornhuber, Johannes, Peters, Oliver, Naj, Adam C., Chouraki, Vincent, Bellenguez, Céline, Gerrish, Amy, Heun, Reiner, Frölich, Lutz, Hüll, Michael, Buscemi, Lara

Volltext öffnen

White paper by the Society for CSF Analysis and Clinical Neurochemistry Overcoming barriers in biomarker development and clinical translation von Teunissen, Charlotte E., Otto, Markus, Engelborghs, Sebastiaan, Herukka, Sanna-Kaisa, Lehmann, Sylvain, Lewczuk, Piotr, Lleó, Alberto, Perret-Liaudet, Armand, Tumani, Hayrettin, Turner, Martin R., Verbeek, Marcel M., Wiltfang, Jens, Zetterberg, Henrik, Parnetti, Lucilla, Blennow, Kaj

Volltext öffnen

Cerebrospinal fluid in neurologic disorders /

Weitere Verfasser: Volltext öffnen

Cerebrospinal Fluid Biomarkers

Weitere Verfasser: “… Teunissen, Charlotte E. …”

Volltext öffnen Volltext öffnen

Cerebrospinal fluid in neurologic disorders

Weitere Verfasser: